Literature DB >> 3523811

Gingival enlargement. A comparison between cyclosporine and azathioprine treated renal allograft recipients.

J Friskopp, G Klintmalm.   

Abstract

The immunosuppressive drug cyclosporine (CsA) which is used to facilitate renal transplantations, has shown several side effects. Gingival hyperplasia has been demonstrated in animal experiments and also during treatment of humans. In the present study the prevalence of gingival enlargement was investigated in a group of patients treated with CsA. The results were compared with those obtained from a time matched control group of patients treated with azathioprine. The CsA treated patients showed a high prevalence of gingival enlargement, while the azathioprine treated patients showed none. Edentulous patients showed no gingival enlargement. The gingival enlargement was confined to the free gingiva and the interdental papilla, and had a rough surface, with small fissures. It was extremely fragile and bled on probing. Oral hygiene measures showed a slight reduction of the size of the gingival enlargement.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3523811

Source DB:  PubMed          Journal:  Swed Dent J        ISSN: 0347-9994


  4 in total

Review 1.  Gingival enlargement induced by drugs.

Authors:  L Brunet; J Miranda; M Farré; L Berini; C Mendieta
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 2.  Oro-dental health in children with chronic renal failure and after renal transplantation: a clinical review.

Authors:  Victoria S Lucas; Graham J Roberts
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

3.  Conservative management of amlodipine influenced gingival enlargement.

Authors:  Rashmi P Dhale; Mangesh B Phadnaik
Journal:  J Indian Soc Periodontol       Date:  2009-01

Review 4.  Cyclosporine A: Novel concepts in its role in drug-induced gingival overgrowth.

Authors:  Deepa Ponnaiyan; Visakan Jegadeesan
Journal:  Dent Res J (Isfahan)       Date:  2015 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.